China Pharma Holdings Inc. (CPHI): Forecast Levels Chart

Corporate company logo of China Pharma (CPHI)

China Pharma Holdings (CPHI) produces affordable psychotropic generics, where scaling is constrained by component pricing. The business relies on steady sales of core medications in China, despite government price regulations. A mature drug portfolio serves as a cash generator, although margins remain stagnant. The market valuation trend, standing at 0.00, confirms these fundamental indicators of the company.

CPHI: China Pharma Analyst Consensus Forecast 07/04/2022 - 11/16/2026

Analytical breakdowns for China Pharma Holdings Inc. (CPHI)

General company analysis:CPHI China Pharma Holdings
Flagship merchandise of China Pharma Holdings, Inc.

The consensus forecast aggregates estimates from leading investment houses into a single trajectory, allowing market noise to be filtered out to determine the asset's fair fundamental value. The trend in the average market price target reflects analysts' confidence in the ability of China Pharma Holdings (CPHI) to maintain profitability through regional logistics amidst strict government price controls and competitor dumping.